Lactose DC Granules are pharmaceutical excipient granules based on lactose and developed for applications involving direct compression and other pharmaceutical powder-processing operations. Lactose is an established pharmaceutical excipient commonly used as a diluent or filler in oral solid formulations. Depending on the grade, lactose may be supplied as lactose monohydrate, anhydrous lactose or a defined combination of lactose forms.
The current USP-NF maintains separate monographs for Lactose Monohydrate and Anhydrous Lactose. Lactose Monohydrate is defined as the monohydrate of O-β-D-galactopyranosyl-(1→4)-α-D-glucopyranose, while Anhydrous Lactose may consist of β-lactose or a mixture of β- and α-lactose. Therefore, the exact lactose form should always correspond to the actual product specification.
Lactose DC Granules are granulated lactose excipient particles intended for direct-compression formulation applications. The granulated format can provide controlled particle characteristics and handling properties that are important during pharmaceutical powder processing.
Direct compression involves blending formulation components and compressing the blend into tablets without a conventional wet-granulation step. For this process, excipient properties such as flowability, particle-size distribution, density, compressibility and compactability can influence manufacturing performance.
Lactose DC Granules can therefore be developed with physical characteristics appropriate for direct-compression applications. Exact particle-size and density specifications should be based on the actual commercial grade.
Lactose is a carbohydrate excipient widely used in pharmaceutical formulations. It can function primarily as a filler or diluent, contributing bulk to oral solid formulations.
Lactose exists in different physical and crystalline forms. Lactose Monohydrate contains water of crystallization, while Anhydrous Lactose does not contain the stoichiometric water associated with the monohydrate form. USP-NF treats these as separate compendial materials.
This difference can affect physical characteristics such as moisture, density, crystallinity and processing behavior. Consequently, the exact lactose form is an important part of the product identity.
Direct-compression excipients are selected based on physical and mechanical characteristics that allow consistent powder handling, die filling and tablet formation.
For Lactose DC Granules, important characteristics may include:
These characteristics can influence the behavior of a formulation during blending and compression.
Research and USP continuous-manufacturing studies distinguish spray-dried, anhydrous and granulated lactose grades and evaluate properties such as particle-size distribution and bulk/tapped density. USP-supported research has also reported that granulated lactose grades can exhibit different feeding behavior from other lactose forms.
Lactose DC Granules can be used in tablet formulations where a granulated lactose excipient is appropriate for direct compression.
The physical structure of granules can affect powder flow, packing and die filling. Suitable particle-size distribution can help support consistent feeding and blending, while appropriate compressibility and compactability can contribute to tablet formation.
The final tablet properties depend on the complete formulation. Active ingredient properties, lactose grade, other excipients, lubricant level, compression force, tooling and tablet geometry can all influence tablet performance.
Therefore, Lactose DC Granules should be evaluated together with the complete formulation during product development.
Particle size is an important characteristic of granulated lactose. A controlled particle-size distribution can contribute to consistent powder movement, blending and processing.
Depending on the product grade, particle-size specifications may include sieve distribution or D10, D50 and D90 values.
Flow properties may also be evaluated through bulk density, tapped density, Hausner ratio, Carr index or other suitable methods.
These numerical values should not be presented as universal specifications because different lactose DC grades can have different physical characteristics. The values on the SDP page should be taken from the actual product specification or certificate of analysis.
Bulk and tapped density are useful physical characteristics when evaluating excipients intended for direct compression.
Bulk density describes the mass-to-volume relationship before standardized tapping, while tapped density describes the corresponding value after a defined tapping procedure.
For Lactose DC Granules, these parameters can affect hopper filling, powder transport, die filling and tablet weight consistency.
Where SDP has approved bulk-density and tapped-density specifications, these values can be added to the detailed product information.
The exact lactose form should be clearly identified on the product page.
USP-NF currently maintains a Lactose Monohydrate monograph and an Anhydrous Lactose monograph. (doi.usp.org)
Lactose Monohydrate has the formula C₁₂H₂₂O₁₁·H₂O and a molecular weight of approximately 360.32 g/mol. Anhydrous lactose has the formula C₁₂H₂₂O₁₁ and a molecular weight of approximately 342.30 g/mol.
Therefore, if the SDP product is specifically lactose monohydrate DC granules, the page should state that form rather than simply calling it lactose.
Moisture is an important consideration for lactose excipients, particularly when selecting between monohydrate and anhydrous forms.
Lactose Monohydrate contains water of crystallization as part of its defined chemical form, while anhydrous lactose has a different hydration state. USP's current monographs distinguish the two materials.
For this reason, the CMS fields for Loss on Drying and Water Content should not automatically contain the same value.
The applicable moisture specification should be taken from the actual grade and certificate of analysis.
Lactose DC Granules can be considered for:
The suitability of the material depends on the formulation composition and the physical characteristics of the selected lactose grade.
During formulation development, Lactose DC Granules can be evaluated for flow, compressibility, compactability, particle-size distribution, density, moisture and compatibility with other formulation components.
Tablet development may additionally evaluate tablet hardness, friability, disintegration and dissolution.
These performance characteristics are formulation-dependent and should be established experimentally for the intended product.
Pharmaceutical-grade Lactose DC Granules can be evaluated for identity, lactose content, moisture, residue on ignition, optical rotation, particle-size distribution and microbial quality, as applicable to the specific lactose form and pharmacopoeial standard.
The current USP-NF recognizes Lactose Monohydrate and Anhydrous Lactose as separate materials, so the applicable testing should correspond to the actual lactose form.
Where USP/NF compliance is claimed, the material should comply with the current applicable USP-NF monograph.
Lactose DC Granules can be used in the development and manufacture of pharmaceutical tablets and other oral solid dosage forms where a direct-compression lactose excipient is suitable.
The granulated format can be selected when controlled particle characteristics and powder-handling properties are required. The exact application depends on the lactose form, grade and formulation design.
| Parameter | Specification |
|---|---|
| Appearance | white to off-white crystalline powder |
| Identification | IR & HPLC compliant |
| Assay (HPLC) | 98.0% – 102.0% |
| Loss on Drying | NMT 1.0% |
| Residue on Ignition | NMT 0.2% |
| pH (1% Solution) | 2.0 – 4.0 |
| Individual Impurity | NMT 0.5% |
| Water Content | NMT 0.5% |